Skip to main content


Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2016

Ausgabe 3/2016

Inhaltsverzeichnis ( 22 Artikel )

18.07.2016 | Review | Ausgabe 3/2016

Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies

Philip E. Lee, Mary C. Tierney, Wei Wu, Kathleen I. Pritchard, Paula A. Rochon

21.07.2016 | Review | Ausgabe 3/2016

Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status

Martinus A. Beek, Paul D. Gobardhan, Ernst J. P. Schoenmaeckers, Elisabeth G. Klompenhouwer, Harm J. T. Rutten, Adri C. Voogd, Ernest J. T. Luiten

06.07.2016 | Preclinical study | Ausgabe 3/2016

Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants

Saeam Shin, In Sik Hwang, Seung-Tae Lee, Jong Rak Choi

08.07.2016 | Preclinical study | Ausgabe 3/2016 Open Access

Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion

Abhijit Mazumdar, Graham M. Poage, Jonathan Shepherd, Anna Tsimelzon, Zachary C. Hartman, Petra Den Hollander, Jamal Hill, Yun Zhang, Jenny Chang, Susan G. Hilsenbeck, Suzanne Fuqua, C. Kent Osborne, Gordon B. Mills, Powel H. Brown

08.07.2016 | Preclinical study | Ausgabe 3/2016

Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer

Juan Zhang, Jie Sun, Jiuan Chen, Lu Yao, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Yuntao Xie

20.07.2016 | Preclinical study | Ausgabe 3/2016 Open Access

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families

Taru A. Muranen, Nasim Mavaddat, Sofia Khan, Rainer Fagerholm, Liisa Pelttari, Andrew Lee, Kristiina Aittomäki, Carl Blomqvist, Douglas F. Easton, Heli Nevanlinna

08.07.2016 | Clinical trial | Ausgabe 3/2016

Characteristics and prognosis of interval cancers after biennial screen-film or full-field digital screening mammography

Roy J. P. Weber, Rob M. G. van Bommel, Marieke W. Louwman, Joost Nederend, Adri C. Voogd, Frits H. Jansen, Vivianne C. G. Tjan-Heijnen, Lucien E. M. Duijm

08.07.2016 | Clinical trial | Ausgabe 3/2016 Open Access

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer

Z. A. Nahleh, W. E. Barlow, D. F. Hayes, A. F. Schott, J. R. Gralow, W. M. Sikov, E. A. Perez, S. Chennuru, H. R. Mirshahidi, S. W. Corso, D. L. Lew, L. Pusztai, R. B. Livingston, G. N. Hortobagyi

09.07.2016 | Clinical trial | Ausgabe 3/2016

Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial

Scott C. Adams, Roanne J. Segal, Donald C. McKenzie, James R. Vallerand, Andria R. Morielli, John R. Mackey, Karen Gelmon, Christine M. Friedenreich, Robert D. Reid, Kerry S. Courneya

11.07.2016 | Clinical trial | Ausgabe 3/2016

Effect of a multidiscipline mentor-based program, Be Resilient to Breast Cancer (BRBC), on female breast cancer survivors in mainland China—A randomized, controlled, theoretically-derived intervention trial

Zeng Jie Ye, Mu Zi Liang, Hong Zhong Qiu, Mei Ling Liu, Guang Yun Hu, Yun Fei Zhu, Zhen Zeng, Jing Jing Zhao, Xiao Ming Quan

18.07.2016 | Clinical trial | Ausgabe 3/2016

The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis

Tracy A. Battaglia, Julie S. Darnell, Naomi Ko, Fred Snyder, Electra D. Paskett, Kristen J. Wells, Elizabeth M. Whitley, Jennifer J. Griggs, Anand Karnad, Heather Young, Victoria Warren-Mears, Melissa A. Simon, Elizabeth Calhoun

21.07.2016 | Clinical trial | Ausgabe 3/2016

Ultrasound-guided breast-conserving surgery for early-stage palpable and nonpalpable invasive breast cancer: decreased excision volume at unchanged tumor-free resection margin

W. A. Slijkhuis, E. M. Noorda, H. van der Zaag-Loonen, M. J. Bolster-van Eenennaam, K. E. Droogh-de Greve, W. B. Lastdrager, J. W. C. Gratama

08.07.2016 | Epidemiology | Ausgabe 3/2016

Patterns and determinants of receipt of follow-up mammography and/or clinical examination in a cohort of Italian breast cancer survivors

Orietta Giuliani, Silvia Mancini, Donella Puliti, Nicola Caranci, Alessandra Ravaioli, Rosa Vattiato, Monica Palumbo, Americo Colamartini, Annibale Biggeri, Lauro Bucchi, Dino Amadori, Fabio Falcini

09.07.2016 | Epidemiology | Ausgabe 3/2016

A novel approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly women

Giorgio Secreto, Sabina Sieri, Claudia Agnoli, Sara Grioni, Paola Muti, Barnett Zumoff, Milena Sant, Elisabetta Meneghini, Vittorio Krogh

14.07.2016 | Epidemiology | Ausgabe 3/2016 Open Access

Predictors of enduring clinical distress in women with breast cancer

Deborah N. N. Lo-Fo-Wong, Hanneke C. J. M. de Haes, Neil K. Aaronson, Doris L. van Abbema, Mathilda D. den Boer, Marjan van Hezewijk, Marcelle Immink, Ad A. Kaptein, Marian B. E. Menke-Pluijmers, Anna K. L. Reyners, Nicola S. Russell, Manon Schriek, Sieta Sijtsema, Geertjan van Tienhoven, Mirjam A. G. Sprangers

15.07.2016 | Epidemiology | Ausgabe 3/2016

Effects of state-level medicaid policies and patient characteristics on time to breast cancer surgery among medicaid beneficiaries

Michael T. Halpern, Deborah Schrag

21.07.2016 | Epidemiology | Ausgabe 3/2016

Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study

Anand K. Narayan, Kala Visvanathan, Susan C. Harvey

11.07.2016 | Brief Report | Ausgabe 3/2016

Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials

Adam R. Brentnall, Jack Cuzick, Helen Byers, Corrinne Segal, Caroline Reuter, Simone Detre, Ivana Sestak, Anthony Howell, Trevor J. Powles, William G. Newman, Mitchell Dowsett

08.07.2016 | Letter to the Editor | Ausgabe 3/2016

Perioperative biology in primary breast cancer: selective targeting of vasopressin type 2 receptor using desmopressin as a novel therapeutic approach

Juan Garona, Daniel F. Alonso

11.07.2016 | Letter to the Editor | Ausgabe 3/2016

Mastectomy versus breast conservation treatment: is there a true survival difference?

Mona P. Tan

13.07.2016 | Retraction Note | Ausgabe 3/2016

Retraction Note to: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways

Aamir Ahmad, Zhiwei Wang, Dejuan Kong, Raza Ali, Shadan Ali, Sanjeev Banerjee, Fazlul H. Sarkar

13.07.2016 | Retraction Note | Ausgabe 3/2016

Retraction Note to: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors

Aamir Ahmad, Zhiwei Wang, Dejuan Kong, Shadan Ali, Yiwei Li, Sanjeev Banerjee, Raza Ali, Fazlul H. Sarkar

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

07.05.2021 | DDG-Tagung 2021 | Kongressbericht | Nachrichten

Prävention von aktinischen Keratosen intensivieren

07.05.2021 | DDG-Tagung 2021 | Kongressbericht | Nachrichten

Von Wirkung und Nebenwirkung

07.05.2021 | DDG-Tagung 2021 | Kongressbericht | Nachrichten

Progredienzangst frühzeitig erkennen

07.05.2021 | DDG-Tagung 2021 | Kongressbericht | Nachrichten

Schleimhautmelanom: Neue Therapieoption in Sicht?

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.